Geode Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246M | Sell |
1,959,265
-10,489
| -0.5% | -$1.31M | 0.02% | 600 |
|
|
2025
Q1 | $217M | Buy |
1,969,754
+94,692
| +5% | +$10.5M | 0.02% | 608 |
|
|
2024
Q4 | $256M | Buy |
1,875,062
+15,830
| +0.9% | +$2.16M | 0.02% | 561 |
|
|
2024
Q3 | $214M | Buy |
1,859,232
+39,610
| +2% | +$4.55M | 0.02% | 612 |
|
|
2024
Q2 | $250M | Buy |
1,819,622
+105,908
| +6% | +$14.6M | 0.02% | 525 |
|
|
2024
Q1 | $236M | Buy |
1,713,714
+90,590
| +6% | +$12.5M | 0.02% | 550 |
|
|
2023
Q4 | $214M | Buy |
1,623,124
+68,494
| +4% | +$9.01M | 0.02% | 543 |
|
|
2023
Q3 | $175M | Buy |
1,554,630
+31,222
| +2% | +$3.51M | 0.02% | 565 |
|
|
2023
Q2 | $143M | Buy |
1,523,408
+87,671
| +6% | +$8.25M | 0.02% | 608 |
|
|
2023
Q1 | $145M | Buy |
1,435,737
+47,042
| +3% | +$4.76M | 0.02% | 586 |
|
|
2022
Q4 | $166M | Buy |
1,388,695
+71,001
| +5% | +$8.47M | 0.02% | 539 |
|
|
2022
Q3 | $140M | Buy |
1,317,694
+37,089
| +3% | +$3.94M | 0.02% | 575 |
|
|
2022
Q2 | $125M | Sell |
1,280,605
-3,434
| -0.3% | -$334K | 0.02% | 610 |
|
|
2022
Q1 | $120M | Buy |
1,284,039
+46,491
| +4% | +$4.35M | 0.02% | 682 |
|
|
2021
Q4 | $105M | Buy |
1,237,548
+25,327
| +2% | +$2.15M | 0.01% | 795 |
|
|
2021
Q3 | $116M | Buy |
1,212,221
+9,087
| +0.8% | +$870K | 0.02% | 713 |
|
|
2021
Q2 | $117M | Buy |
1,203,134
+23,626
| +2% | +$2.3M | 0.02% | 712 |
|
|
2021
Q1 | $115M | Buy |
1,179,508
+53,898
| +5% | +$5.24M | 0.02% | 688 |
|
|
2020
Q4 | $108M | Buy |
1,125,610
+59,008
| +6% | +$5.65M | 0.02% | 659 |
|
|
2020
Q3 | $102M | Sell |
1,066,602
-42,408
| -4% | -$4.07M | 0.02% | 596 |
|
|
2020
Q2 | $135M | Buy |
1,109,010
+36,376
| +3% | +$4.43M | 0.03% | 481 |
|
|
2020
Q1 | $92.8M | Buy |
1,072,634
+37,404
| +4% | +$3.23M | 0.02% | 523 |
|
|
2019
Q4 | $111M | Buy |
1,035,230
+52,052
| +5% | +$5.59M | 0.02% | 571 |
|
|
2019
Q3 | $88.6M | Buy |
983,178
+6,854
| +0.7% | +$618K | 0.02% | 615 |
|
|
2019
Q2 | $82.4M | Buy |
976,324
+27,195
| +3% | +$2.3M | 0.02% | 646 |
|
|
2019
Q1 | $83.6M | Buy |
949,129
+41,837
| +5% | +$3.69M | 0.02% | 604 |
|
|
2018
Q4 | $64.8M | Buy |
907,292
+36,508
| +4% | +$2.61M | 0.02% | 624 |
|
|
2018
Q3 | $107M | Buy |
870,784
+33,581
| +4% | +$4.13M | 0.03% | 515 |
|
|
2018
Q2 | $82.2M | Buy |
837,203
+51,850
| +7% | +$5.09M | 0.03% | 568 |
|
|
2018
Q1 | $65.1M | Buy |
785,353
+22,518
| +3% | +$1.87M | 0.02% | 621 |
|
|
2017
Q4 | $59.2M | Buy |
762,835
+12,347
| +2% | +$958K | 0.02% | 637 |
|
|
2017
Q3 | $46M | Buy |
750,488
+34,097
| +5% | +$2.09M | 0.02% | 723 |
|
|
2017
Q2 | $33M | Buy |
716,391
+39,068
| +6% | +$1.8M | 0.01% | 863 |
|
|
2017
Q1 | $29.3M | Buy |
677,323
+42,752
| +7% | +$1.85M | 0.01% | 904 |
|
|
2016
Q4 | $24.6M | Buy |
634,571
+52,232
| +9% | +$2.02M | 0.01% | 945 |
|
|
2016
Q3 | $29.5M | Buy |
582,339
+28,908
| +5% | +$1.46M | 0.01% | 761 |
|
|
2016
Q2 | $25.2M | Sell |
553,431
-29,538
| -5% | -$1.34M | 0.01% | 807 |
|
|
2016
Q1 | $23.1K | Buy |
582,969
+28,169
| +5% | +$1.11K | 0.01% | 843 |
|
|
2015
Q4 | $31.4M | Buy |
554,800
+19,003
| +4% | +$1.07M | 0.02% | 682 |
|
|
2015
Q3 | $21.3M | Buy |
535,797
+7,610
| +1% | +$303K | 0.01% | 856 |
|
|
2015
Q2 | $25.2M | Buy |
528,187
+33,953
| +7% | +$1.62M | 0.01% | 801 |
|
|
2015
Q1 | $19.6M | Buy |
494,234
+68,026
| +16% | +$2.7M | 0.01% | 929 |
|
|
2014
Q4 | $9.52M | Buy |
426,208
+10,535
| +3% | +$235K | 0.01% | 1375 |
|
|
2014
Q3 | $6.51M | Buy |
415,673
+1,577
| +0.4% | +$24.7K | ﹤0.01% | 1592 |
|
|
2014
Q2 | $6.15M | Buy |
414,096
+8,367
| +2% | +$124K | ﹤0.01% | 1655 |
|
|
2014
Q1 | $6.53M | Buy |
405,729
+93,806
| +30% | +$1.51M | ﹤0.01% | 1572 |
|
|
2013
Q4 | $2.91M | Buy |
311,923
+26,234
| +9% | +$245K | ﹤0.01% | 2075 |
|
|
2013
Q3 | $3.23M | Buy |
285,689
+35,667
| +14% | +$404K | ﹤0.01% | 1879 |
|
|
2013
Q2 | $3.35M | Buy |
+250,022
| New | +$3.35M | ﹤0.01% | 1702 |
|